Director of Vanderbilt Vaccine Research Program at Vanderbilt University Medical Center.
Safety and Immunogenicity Results For Mpox Vaccine MVA-BN in Adolescents Amid Rising Concerns
Buddy Creech, MD, MPH, assures that the interim findings of the study indicate adolescents produced a stronger immune response compared to adults, with minimal adverse effects.
Read More